Anzeige
❌
Mehr »
Samstag, 24.10.2026 - Börsentäglich über 12.000 News
Hotspot Rohstoffe: Neuer Highflyer abseits des Rampenlichts?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrStoneX reiterates Buy on Abbott Labs stock, $120 target unchanged
FrUBS lowers CACI International stock price target on valuation
FrUBS cuts CoreWeave stock price target to $105 on AI infrastructure concerns
FrUBS reiterates Union Pacific stock rating on strong volume growth
FrKyverna reports phase 1 data for MS therapy miv-cel
FrBristol Myers Squibb reports interim results for MS cell therapy
FrDA Davidson raises Civista Bancshares stock price target on margin lift
FrFBN Securities raises RingCentral stock price target on AI growth
FrD.A. Davidson reiterates Banner stock Neutral rating with $76 target
FrBank of India Q2 FY27 slides: profit surges 25% amid asset quality gains
FrCTS completes $50M acquisition of Millar Holdings
FrSika Q3 2026 slides: growth accelerates to 4.8% amid transformation
FrFirst Interstate Q3 2026 slides: margin gains continue amid balance sheet contraction
FrFirst Citizens Q3 2026 slides: balance sheet growth offsets margin pressure
FrTD Cowen raises Union Pacific stock price target on volume growth
FrBMO cuts Honeywell stock price target on margin questions
FrBMO raises Waste Connections stock price target on growth outlook
FrBMO raises Roper Industries stock price target on solid earnings
FrTD Cowen reiterates argenx stock Buy rating on Vyvgart strength
FrGoldman Sachs stock rating upgraded at Freedom Broker on strong Q3 results
FrBMO cuts FirstService stock price target on sector valuation pressure
FrBMO cuts Celestica stock price target on valuation review
FrDCB Bank Q2 FY27 slides: record profit amid margin headwinds
FrZentalis reports survival data for ovarian cancer drug trial
FrBeOne reports extended survival data from cancer drug trial